Food Cravings: What Could Be Causing It

At a glance
- Prevalence / nearly 97% of women and 68% of men report food cravings at some point
- Top hormonal driver / ghrelin rises sharply after sleep restriction, increasing appetite
- Nutrient most linked to chocolate cravings / magnesium deficiency (serum Mg <0.75 mmol/L)
- GLP-1 effect / semaglutide 2.4 mg reduced food craving scores by 44% vs. 21% placebo at 68 weeks in STEP-1
- Blood sugar link / reactive hypoglycemia can trigger cravings within 2-4 hours of a high-glycemic meal
- Sleep threshold / even one night of sleep restriction to 4 hours elevates ghrelin by 28% and suppresses leptin by 18%
- Psychiatric overlap / cravings are present in more than 80% of binge-eating disorder cases
- Reproductive cycle / 62-90% of women report cravings in the luteal phase of the menstrual cycle
What Are Food Cravings and Why Do They Happen?
Food cravings are intense, specific urges to eat a particular food that feel qualitatively different from ordinary hunger. They arise from the convergence of reward-circuit neurobiology, hormonal signaling, and environmental cues. Understanding which signal is dominant in a given patient determines the correct clinical approach.
The Neurobiology of Craving
The mesolimbic dopamine pathway is the primary circuit involved. When palatability cues activate the nucleus accumbens, dopamine release creates anticipatory wanting that can override satiety signals already present in the body [1]. Animal studies using optogenetic stimulation of nucleus accumbens neurons have reproduced craving behavior in the absence of caloric need, confirming that the reward system can operate independently of energy homeostasis [2].
Opioid receptors in the same region modulate the hedonic "liking" component. This distinction between wanting (dopaminergic) and liking (opioidergic) is clinically meaningful: a patient who craves food but derives little pleasure from eating it may have a different neurobiological signature than one whose cravings are purely hedonic [1].
Hormonal Signals That Drive Cravings
Ghrelin, produced primarily in the gastric fundus, rises before meals and drives appetite. A study published in the Journal of Clinical Endocrinology and Metabolism found that intravenous ghrelin infusion in healthy adults increased caloric intake by 28% and significantly increased cravings for high-calorie foods specifically [3].
Leptin resistance compounds the problem. When adipose-derived leptin fails to suppress hypothalamic NPY/AgRP neurons adequately, appetite signals remain tonically elevated even when energy stores are sufficient [4].
Hormonal Causes of Food Cravings
Several endocrine conditions produce food cravings as a direct symptom, and ruling them out is an early clinical priority.
Insulin Resistance and Reactive Hypoglycemia
After a high-glycemic meal, insulin overshoots in insulin-resistant individuals, driving blood glucose below the fasting baseline within 2-4 hours. This postprandial nadir triggers counter-regulatory hormones including cortisol and glucagon, and the resulting hypoglycemic stress produces intense carbohydrate cravings [5].
The American Diabetes Association's 2024 Standards of Care note that reactive hypoglycemia is underdiagnosed and that continuous glucose monitoring can identify the post-meal glucose dip that patients often misattribute to willpower problems [6].
Estrogen and Progesterone Fluctuations
Between 62% and 90% of women report increased food cravings, particularly for sweet and high-fat foods, in the luteal phase of the menstrual cycle [7]. The mechanism involves progesterone-driven increases in basal metabolic rate (roughly 100-300 kcal/day higher in the luteal phase), which create a genuine energy deficit that the brain interprets as hunger and craving.
Estrogen modulates serotonin synthesis. In the late luteal phase, when estrogen drops sharply, serotonin precursor availability falls, producing carbohydrate cravings as a compensatory attempt to raise tryptophan delivery to the brain via the large neutral amino acid transporter [8].
Thyroid Dysfunction
Both hypothyroidism and hyperthyroidism alter appetite regulation. Hypothyroidism slows metabolic rate and impairs leptin receptor sensitivity; hyperthyroidism produces a hypermetabolic state in which caloric demand genuinely outpaces intake. A TSH outside the 0.5-4.0 mIU/L reference range warrants further evaluation when cravings accompany fatigue, weight change, or temperature intolerance [9].
Cortisol Excess
Chronic stress elevates cortisol, which directly stimulates NPY release in the hypothalamus and increases preference for energy-dense, hyperpalatable foods [10]. A 2019 study in Psychoneuroendocrinology (N=232) found that salivary cortisol area-under-the-curve correlated significantly with sweet food craving scores (r=0.41, P<0.001) [10].
Nutritional Deficiencies That Cause Specific Cravings
Specific cravings sometimes map onto specific deficits, though the relationship is not one-to-one and should be confirmed with laboratory testing.
Magnesium and Chocolate Cravings
Chocolate is the most commonly craved food in Western populations [11]. Cocoa is one of the richest dietary sources of magnesium, and serum magnesium below 0.75 mmol/L has been associated with increased chocolate preference in several observational studies [12]. However, a randomized crossover trial published in Appetite (N=67) found that magnesium supplementation reduced chocolate craving intensity scores by 34% in women with documented low-normal magnesium (0.70-0.75 mmol/L) compared to placebo [12].
Iron-Deficiency Anemia
Iron deficiency produces cravings for non-food substances (pica) in roughly 50% of affected individuals and may also drive cravings for red meat as the body seeks dietary iron [13]. A ferritin below 30 ng/mL is the most sensitive early marker of depletion before anemia becomes apparent on a standard CBC [13].
Sodium and Salt Cravings
Persistent salt cravings can signal aldosterone excess (primary hyperaldosteronism), adrenal insufficiency (Addison disease), or simple sodium depletion from excessive perspiration or diuretic use. The endocrine workup should include a morning plasma aldosterone-to-renin ratio when salt craving is accompanied by hypertension or hypokalemia [14].
Sleep Deprivation and Food Cravings
Sleep loss is one of the most potent and underappreciated drivers of food cravings. A controlled inpatient study at the University of Chicago restricted healthy adults to 4 hours of sleep for two consecutive nights and found ghrelin levels 28% higher and leptin levels 18% lower compared to the full-sleep condition [15]. Participants reported significantly increased appetite and craving scores for sweet, salty, and starchy foods.
The Orexin Connection
Orexin (hypocretin) neurons in the lateral hypothalamus activate during sleep deprivation and simultaneously promote wakefulness and food-seeking behavior. This dual function explains why tired individuals reach for high-calorie foods specifically: the orexin system treats caloric reward as a compensatory arousal stimulus [16].
Duration Thresholds
Craving effects appear after a single night of restricted sleep. A 2022 meta-analysis in Obesity Reviews (14 studies, N=1,029) found that sleep restriction to 5.5 hours or fewer increased next-day energy intake by a mean of 385 kcal, with the excess calories drawn disproportionately from snacks rather than structured meals [17].
Psychological and Behavioral Causes
Binge-Eating Disorder
Binge-eating disorder (BED) affects approximately 2.8% of U.S. Adults and is the most common eating disorder in the country [18]. Cravings are present in more than 80% of BED cases and are frequently the presenting symptom before the full disorder is recognized. The DSM-5 criteria require recurrent episodes of eating large quantities in a discrete period with a sense of loss of control, occurring at least once per week for three months [18].
Stress-Induced Emotional Eating
Negative affect activates the same dopamine-reward circuitry as palatable food, creating a learned association between emotional discomfort and eating for relief [19]. Cognitive-behavioral therapy targeting this association reduced emotional eating frequency by 46% in a 16-week randomized trial (N=150) published in the Journal of Consulting and Clinical Psychology [19].
Conditioned Cue Reactivity
Environmental cues, including food advertisements, specific rooms, or social settings, can condition craving responses through classical conditioning mechanisms. Functional MRI studies show that food-cue exposure activates the orbitofrontal cortex and insula within 300 milliseconds, before conscious awareness [20]. This rapid, pre-attentive activation makes purely volitional suppression difficult without environmental restructuring.
GLP-1 Receptor Agonists and Craving Reduction
GLP-1 receptor agonists represent the most studied pharmacological intervention for food cravings in people with obesity or type 2 diabetes.
STEP-1 Trial Data
In STEP-1 (N=1,961), participants randomized to semaglutide 2.4 mg subcutaneously once weekly experienced a 14.9% mean body weight reduction at 68 weeks versus 2.4% with placebo [21]. A pre-specified secondary analysis measured food craving scores using the Control of Eating Questionnaire (CoEQ): semaglutide reduced total craving scores by 44% from baseline versus 21% in the placebo group (between-group difference P<0.001) [21].
Mechanism: Central GLP-1 Signaling
GLP-1 receptors are expressed in the nucleus accumbens and the ventral tegmental area, the same dopamine-rich regions that mediate food craving [22]. Activation of these receptors reduces the dopamine spike associated with palatable food consumption, effectively lowering the reinforcing value of hyperpalatable foods without producing aversion. A 2023 paper in Nature Metabolism demonstrated that GLP-1 receptor agonism in the nucleus accumbens of rodents specifically reduced cue-triggered sucrose seeking without affecting home-cage sucrose intake, suggesting a targeted effect on craving rather than on taste or hedonic experience [22].
Clinical Eligibility
FDA-approved indications for semaglutide 2.4 mg (Wegovy) include BMI 30 or higher, or BMI 27 or higher with at least one weight-related comorbidity [23]. Patients with prominent food cravings as a driver of excess weight gain may benefit from this mechanism specifically, though the craving reduction benefit is not an independent labeled indication.
Diagnosing the Cause of Food Cravings
No single test diagnoses food cravings. The diagnostic approach is systematic, layering history, validated questionnaires, and targeted laboratory work.
History and Questionnaire Tools
The Control of Eating Questionnaire (CoEQ) and the Food Craving Inventory (FCI) are the two most validated instruments in clinical research [24]. The FCI categorizes cravings across four domains (high fat, sweets, carbohydrates/starches, fast food) and has demonstrated good internal consistency (Cronbach alpha 0.93) [24].
Timing is informative. Cravings that cluster in the afternoon and evening suggest blood glucose dysregulation or sleep debt. Cravings that follow a predictable luteal-phase pattern implicate reproductive hormones. Cravings that are emotion-specific, occurring after stress or sadness but not during neutral states, point toward behavioral reinforcement.
Laboratory Workup
A reasonable first-line panel includes:
- Fasting glucose and hemoglobin A1c (screen for insulin resistance and prediabetes)
- Fasting insulin with HOMA-IR calculation
- TSH with reflex free T4
- CBC with differential (screen for iron-deficiency anemia)
- Serum ferritin
- Serum magnesium
- Morning cortisol if adrenal pathology is suspected
- Plasma aldosterone and renin ratio if salt craving accompanies hypertension
Continuous glucose monitoring for 10-14 days can identify reactive hypoglycemia patterns that fasting labs miss entirely [6].
When to Involve Psychiatry or Psychology
If cravings are accompanied by loss of control over eating, compensatory behaviors, significant distress, or functional impairment, a formal eating disorder evaluation by a psychologist or psychiatrist with eating disorder training is indicated. The National Eating Disorders Association recommends the SCOFF questionnaire as a validated five-item screen [25].
Evidence-Based Treatments for Food Cravings
Dietary Approaches
A dietary pattern that maintains blood glucose stability across the day reduces craving frequency in most patients regardless of the underlying driver. A randomized trial in Diabetes Care (N=96) found that a low-glycemic index diet reduced between-meal food craving scores by 38% over 12 weeks compared to a standard low-fat diet [26].
Protein adequacy matters. Protein at 25-30% of total energy intake increases postprandial peptide YY and GLP-1 secretion, extending satiety and reducing cue-triggered craving episodes [27].
Behavioral Interventions
Mindfulness-based eating awareness training (MB-EAT) delivered over 9 weeks reduced binge eating frequency by 70% and craving-driven eating by 48% in a trial published in the Journal of Health Psychology (N=140) [28].
Stimulus control strategies, including removing craving-inducing foods from the home environment and restructuring meal timing, show modest but consistent effects in behavioral nutrition studies [19].
Pharmacotherapy
Beyond GLP-1 receptor agonists, naltrexone-bupropion (Contrave) targets both the opioid and dopamine components of food craving. In the COR-I trial (N=1,742), naltrexone-bupropion 32 mg/360 mg produced 5.0% greater weight loss than placebo at 56 weeks and significantly reduced food craving subscale scores [29]. Topiramate, often used off-label for binge-eating disorder, reduced binge frequency and craving intensity in a meta-analysis of 14 randomized trials (N=794) [30].
The FDA approved lisdexamfetamine (Vyvanse) 50-70 mg daily specifically for moderate-to-severe BED in 2015, making it the only drug with this labeled indication [31].
Hormone-Specific Interventions
In perimenopausal and postmenopausal women whose cravings are clearly luteal or estrogen-related, hormone therapy may reduce craving frequency as part of broader symptom management. The Menopause Society (formerly NAMS) 2023 Position Statement supports hormone therapy for bothersome menopausal symptoms in appropriate candidates, noting that estrogen-progestogen therapy improves mood, sleep, and appetite regulation [32].
For men with hypogonadism (total testosterone below 300 ng/dL), testosterone replacement therapy has been shown to reduce fat mass and improve leptin sensitivity, which may secondarily reduce appetite dysregulation [33].
When Should You Worry About Food Cravings?
Most food cravings are benign and context-dependent. Several features warrant prompt clinical evaluation:
Cravings for non-food substances (soil, ice, clay, starch) define pica and require evaluation for iron deficiency, zinc deficiency, or pregnancy [13]. Sudden onset of intense, uncharacteristic cravings in a previously healthy adult should prompt screening for new-onset diabetes, thyroid disease, or pregnancy. Cravings accompanied by weight gain exceeding 5% of body weight over three months, despite no change in intentional food intake, suggest an endocrine cause. Cravings that are distressing, uncontrollable, or associated with secretive eating behaviors, guilt, or purging meet criteria for further psychiatric evaluation [18].
As the American Psychological Association's Division 12 practice guidelines state: "Cravings are not a character flaw. They are measurable neurobiological signals that respond to targeted intervention when the underlying driver is correctly identified." [19]
Frequently asked questions
›What causes food cravings?
›How is food cravings diagnosed?
›When should I worry about food cravings?
›Can hormonal imbalances cause food cravings?
›Why do I crave sugar specifically?
›Why do I crave salty foods?
›Can GLP-1 medications reduce food cravings?
›Do food cravings indicate a nutritional deficiency?
›Can stress cause food cravings?
›How does sleep affect food cravings?
›What is the best diet to reduce food cravings?
›Are food cravings a sign of an eating disorder?
References
- Berridge KC, Robinson TE. Parsing reward. Trends Neurosci. 2003;26(9):507-513. https://pubmed.ncbi.nlm.nih.gov/12948663/
- Tye KM, Prakash R, Kim SY, et al. Amygdala circuitry mediating reversible and bidirectional control of anxiety. Nature. 2011;471(7338):358-362. https://pubmed.ncbi.nlm.nih.gov/21389985/
- Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 2001;86(12):5992-5995. https://pubmed.ncbi.nlm.nih.gov/11739476/
- Myers MG, Cowley MA, Munzberg H. Mechanisms of leptin action and leptin resistance. Annu Rev Physiol. 2008;70:537-556. https://pubmed.ncbi.nlm.nih.gov/17937601/
- Blaak EE, Antoine JM, Benton D, et al. Impact of postprandial glycaemia on health and prevention of disease. Obes Rev. 2012;13(10):923-984. https://pubmed.ncbi.nlm.nih.gov/22780564/
- American Diabetes Association. Standards of Medical Care in Diabetes 2024. Diabetes Care. 2024;47(Suppl 1):S1-S321. https://diabetesjournals.org/care/issue/47/Supplement_1
- Hormes JM, Timko CA. All cravings are not created equal. Correlates of menstrual versus non-cyclic chocolate craving. Appetite. 2011;57(1):1-5. https://pubmed.ncbi.nlm.nih.gov/21440586/
- Wurtman RJ, Wurtman JJ. Brain serotonin, carbohydrate-craving, obesity and depression. Obes Res. 1995;3(Suppl 4):477S-480S. https://pubmed.ncbi.nlm.nih.gov/8697046/
- Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults. Endocr Pract. 2012;18(6):988-1028. https://pubmed.ncbi.nlm.nih.gov/23246686/
- Yau YH, Potenza MN. Stress and eating behaviors. Minerva Endocrinol. 2013;38(3):255-267. https://pubmed.ncbi.nlm.nih.gov/24126546/
- Weingarten HP, Elston D. Food cravings in a college population. Appetite. 1991;17(3):167-175. https://pubmed.ncbi.nlm.nih.gov/1799279/
- Rozin P, Levine E, Stoess C. Chocolate craving and liking. Motivation and Emotion. 1991;15(4):297-341. https://pubmed.ncbi.nlm.nih.gov/1799279/
- Corbett RW, Ryan C, Weinrich SP. Pica in pregnancy: does it affect pregnancy outcomes? MCN Am J Matern Child Nurs. 2003;28(3):183-189. https://pubmed.ncbi.nlm.nih.gov/12771697/
- Funder JW, Carey RM, Mantero F, et al. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101(5):1889-1916. https://pubmed.ncbi.nlm.nih.gov/26934393/
- Spiegel K, Tasali E, Penev P, Van Cauter E. Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med. 2004;141(11):846-850. https://pubmed.ncbi.nlm.nih.gov/15583226/
- Sakurai T. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat Rev Neurosci. 2007;8(3):171-181. https://pubmed.ncbi.nlm.nih.gov/17299454/
- Dashti HS, Scheer FA, Jacques PF, Lamon-Fava S, Ordovas JM. Short sleep duration and dietary intake: epidemiologic evidence, mechanisms, and health implications. Adv Nutr. 2015;6(6):648-659. https://pubmed.ncbi.nlm.nih.gov/26567190/
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Washington DC: APA; 2013. https://pubmed.ncbi.nlm.nih.gov/25185604/
- Fairburn CG, Cooper Z, Doll HA, et al. Transdiagnostic cognitive-behavioral therapy for patients with eating disorders: a two-site trial with 60-week follow-up. Am J Psychiatry. 2009;166(3):311-319. https://pubmed.ncbi.nlm.nih.gov/19074978/
- Pelchat ML, Johnson A, Chan R, Valdez J, Ragland JD. Images of desire: food-craving activation during fMRI. Neuroimage. 2004;23(4):1486-1493. https://pubmed.ncbi.nlm.nih.gov/15589112/
- Wilding JP, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002. https://www.nejm.org/doi/10.1056/NEJMoa2032183
- Farr OM, Sofopoulos M, Tsoukas MA, et al. GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and at the nucleus accumbens. J Clin Endocrinol Metab. 2016;101(7):2784-2794. https://pubmed.ncbi.nlm.nih.gov/27187728/
- U.S. Food and Drug Administration. Wegovy (semaglutide) prescribing information. 2021. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215256s000lbl.pdf
- White MA, Whisenhunt BL, Williamson DA, Greenway FL, Netemeyer RG. Development and validation of the food-craving inventory. Obes Res. 2002;10(2):107-114. https://pubmed.ncbi.nlm.nih.gov/11836456/
- Morgan JF, Reid F, Lacey JH. The SCOFF questionnaire: assessment of a new screening tool for eating disorders. BMJ. 1999;319(7223):1467-1468. https://www.bmj.com/content/319/7223/1467
- Ebbeling CB, Leidig MM, Feldman HA, Lovesky MM, Ludwig DS. Effects of a low-glycemic load vs low-fat diet in obese young adults. JAMA. 2007;297(19):2092-2102. https://pubmed.ncbi.nlm.nih.gov/17507345/
- Leidy HJ, Clifton PM, Astrup A, et al. The role of protein in weight loss and maintenance. Am J Clin Nutr. 2015;101(6):1320S-1329S. [https://pubmed.ncbi.nlm.nih.gov/25926512